PFKFB3 and breast cancer: Unfortunately, we were unable to monitor the impact of chronic CQ administration (5–7 days) on Pfkfb3 expression in D2.OR organoids due to its cytotoxic activities, which were surprisingly similar across several human and murine breast cancer cell lines (Supplementary Fig. 5b–d).